Monitor this situation.

Unsubscribe anytime.

[SITUATION] · [ACTIVE] · [HEALTH]

13 clusters · 164 sources · 61 days · First seen 2 months ago · Last updated 1 day ago

Lito Sousa receives experimental ALN-6457 treatment

Overview

Lito Sousa, a 59-year-old aviation specialist and creator of the YouTube channel ‘Aviões e Músicas’, continues to battle Creutzfeldt-Jakob disease (CJD), a rare and fatal neurodegenerative condition caused by infectious prions.

While previously hospitalized at Hospital Albert Einstein in São Paulo, Sousa was discharged on September 1 to receive palliative care at home. His wife, Mila Seidl, clarified that this transition is intended to manage symptoms rather than signify terminal status, noting that Sousa remains “cognitive, talkative, and capable of thought” despite significant physical deterioration, including the loss of independent mobility and vision.

In a significant medical development, Anvisa has granted exceptional authorization for the importation of ALN-6457, an experimental medication developed by Regeneron Pharmaceuticals. Facilitated by Hospital Israelita Albert Einstein, Sousa is set to become the first person to test this substance for CJD under a compassionate use program. The drug is currently in the pre-clinical stage and has not yet undergone formal clinical trials for this specific prion disease in humans.

The medication arrived in Brazil via an American Airlines flight from New York to Guarulhos International Airport. To preserve its therapeutic potential, an emergency operation involving the Brazilian Federal Revenue and Anvisa allowed for customs clearance within minutes of arrival, after which the drug was transported by helicopter to Hospital Israelita Albert Einstein. Following the administration of the treatment, Mila Seidl reported that Sousa’s condition remains stable. Medical teams will monitor his progress closely over the next six weeks to evaluate the drug's efficacy. Seidl also noted the importance of the visibility surrounding Sousa’s case in accelerating access to experimental medical research in Brazil.

Entities

Lito Sousa · Mila Seidl · Hospital Israelita Albert Einstein · Anvisa · Creutzfeldt-Jakob Disease

Claims

What the coverage asserts, and how many sources carry each claim.

[● 3 SOURCES] Lito Sousa, 59, was diagnosed with prostate cancer after a routine PSA test.
[● 3 SOURCES] Sousa experienced loss of coordination and strength in his left arm during a trip to the United States.
[● 3 SOURCES] The Broad Institute offered Lito Sousa an initial interview for the PRiSM study, but participation would likely be in the control group without the experimental drug. br.paipee.com · hugogloss.uol.com.br · gazetabrasil.com.br
[● 3 SOURCES] Lito Sousa has been diagnosed with Creutzfeldt-Jakob disease (CJD), a rare and incurable neurological condition. diariodopara.com.br · hugogloss.uol.com.br · inmagazine.ig.com.br
[● 3 SOURCES] The family is negotiating with an undisclosed biotechnology company for access to an experimental drug. www.maisnovela.com.br · brasil.perfil.com · diariodoestadogo.com.br
[● 3 SOURCES] Anvisa authorized the use of the experimental drug ALN-6457 under the compassionate use modality. contilnetnoticias.com.br · www.brasil247.com · www.metropoles.com
[● 3 SOURCES] The drug ALN-6457 is developed by Regeneron Pharmaceuticals and is currently in the pre-clinical stage. contilnetnoticias.com.br · www.brasil247.com · www.metropoles.com
[● 3 SOURCES] Lito Sousa has been diagnosed with Creutzfeldt-Jakob disease, a rare neurodegenerative condition caused by prions. contilnetnoticias.com.br · www.brasil247.com · www.metropoles.com
[● 3 SOURCES] The drug ALN-6457 has not yet undergone formal human studies for treating prion-related diseases. contilnetnoticias.com.br · www.brasil247.com · www.metropoles.com
[● 3 SOURCES] The therapeutic potential of the ALN-6457 compound degrades rapidly over time. contilnetnoticias.com.br · www.brasil247.com · www.metropoles.com
[● 2 SOURCES] He chose to undergo a prostatectomy to remove the prostate.
[● 2 SOURCES] He was hospitalized at Hospital Israelita Albert Einstein in São Paulo for nine days.

Timeline

1 day ago

[HEALTH] 2 sources
Lito Sousa receives experimental treatment for Creutzfeldt-Jakob disease
Influencer Lito Sousa is receiving the experimental drug ALN-6457 via compassionate use to treat Creutzfeldt-Jakob disease, a rare and rapidly progressing neurodegenerative condition.
4 days ago

[HEALTH] 19 sources
Lito Sousa receives experimental medication for rare disease
Influencer Lito Sousa has received the experimental drug ALN-6457 for Creutzfeldt-Jakob disease via a rapid, coordinated medical logistics operation in Brazil.
6 days ago

[HEALTH] 9 sources
Lito Sousa to receive experimental Creutzfeldt-Jakob treatment
Pilot Lito Sousa will undergo experimental treatment with ALN-6457 for Creutzfeldt-Jakob disease, following an urgent, coordinated transport of the drug from New York to Hospital Albert Einstein in Brazil.
14 days ago

[HEALTH] 41 sources
Anvisa authorizes experimental drug for influencer Lito Sousa
Anvisa has authorized the exceptional import of experimental drug ALN-6457 for aviation influencer Lito Sousa to treat his rare and fatal Creutzfeldt-Jakob disease.
17 days ago

[HEALTH] 12 sources
Lito Sousa seeks experimental treatment for rare neurodegenerative disease
Influencer Lito Sousa is seeking access to an experimental drug to combat Creutzfeldt-Jakob disease, a rare and fatal neurodegenerative condition with no current cure.
21 days ago

[HEALTH] 24 sources
Lito Sousa battles rare Creutzfeldt-Jakob disease
Brazilian aviation influencer Lito Sousa is battling Creutzfeldt-Jakob disease, a rare neurodegenerative condition. His family is seeking access to experimental clinical trials as he celebrates 4 million YT sub
23 days ago

[HEALTH] 60 sources
Lito Sousa seeks experimental treatment for rare neurological disease
Influencer Lito Sousa, diagnosed with the rare and incurable Creutzfeldt-Jakob disease, is seeking experimental treatment in the US with support from the Brazilian Ministry of Health.
25 days ago

[HEALTH] 56 sources
Lito Sousa seeks experimental treatment for rare neurodegenerative disease
Brazilian aviation influencer Lito Sousa is fighting for access to experimental clinical trials following a diagnosis of Creutzfeldt-Jakob disease, a rare and rapidly progressing neurodegenerative condition.
28 days ago

[HEALTH] 60 sources
Lito Sousa diagnosed with rare Creutzfeldt-Jakob disease
Influencer Lito Sousa has been diagnosed with the rare, fatal neurodegenerative disease Creutzfeldt-Jakob. His family is seeking access to experimental clinical trials to combat the rapid progression.
about 2 months ago

[HEALTH] 3 sources
Lito Sousa reveals prostate cancer diagnosis and brain inflammation
Brazilian influencer Lito Sousa was diagnosed with prostate cancer after a routine PSA test, underwent prostatectomy, then suffered brain inflammation causing left‑arm weakness; he was hospitalized in São Paulo
about 2 months ago

[HEALTH] 6 sources
Lito Sousa discharged, readies prostate cancer surgery
Aviation influencer Lito Sousa was discharged after hospital treatment and is preparing for prostate cancer surgery, pledging to use his YouTube channel to promote cancer awareness.
about 2 months ago

[HEALTH] 6 sources
Lito Sousa battles prostate cancer and central nervous system inflammation
Influencer Lito Sousa is hospitalized for prostate cancer and central nervous system inflammation, aiming to keep creating videos during treatment.
2 months ago

[HEALTH] 17 sources
Brazilian Influencer Lito Sousa Announces Prostate Cancer Diagnosis
Lito Sousa, 59, announced a prostate cancer diagnosis with intermediate aggressiveness, a benign rectal tumor, pending surgery, a lung issue needing biopsy, and left‑arm numbness.

Sources

ac24horas.com · acessa.com · acusticafm.com.br · agorarn.com.br · amazonianarede.com.br · areavip.com.br · aredacao.com.br · atarde.com.br · bahianoticias.com.br · baraoemfoco.com.br · barq-news.com · beefpoint.com.br · bochumerssc.de · bondkn.nl · bouwenwonen.net · bpmoney.com.br · br.paipee.com · brasil.estadao.com.br · brasil.perfil.com · brasil247.com · brasilemfolhas.com.br · brasilparalelo.com.br · capitalnews.com.br · cartacapital.com.br · catracalivre.com.br · cbn.globo.com · cenariomt.com.br · clicrdc.com.br · conexaoto.com.br · contilnetnoticias.com.br · correiodecarajas.com.br · dci.com.br · destakjornal.com.br · dev.tnonline.com.br · dgabc.com.br · diaadianoticia.com.br · diariodecanoas.com.br · diariodocentrodomundo.com.br · diariodoestadogo.com.br · diariodopara.com.br · diariodopara.dol.com.br · diarioonline.com.br · didigalvao.com.br · dol.com.br · dropsdejogos.uai.com.br · em.com.br · espaciodeciencia.org · esporte.ig.com.br

This summary has been updated 33 times: see revision history